Categories
Change Password!
Reset Password!
CBGT-I effectively reduced anxiety and depression in addition to enhancing general psychological health and sleep quality in patients undergoing haemodialysis.
According to a study published in "Behavioural and Cognitive Psychotherapy," nine weekly sessions of cognitive behavioural group therapy for insomnia (CBGT-I) had positive impacts on haemodialysis patients' overall psychological well-being, anxiety, depression, and sleep quality when compared to the control group. Researchers wanted to know how well CBGT-I helped haemodialysis patients with their overall psychological wellness, anxiety, depression, and sleep.
Overall, 116 haemodialysis patients who were randomly allocated to the experimental (n = 58) and control (n = 58) groups participated in this randomized clinical trial. Nine weekly sessions of CBGT-I were given to the experimental group. Working Alliance Inventory-Short Form (WAI-S), Client Satisfaction Questionnaire (CSQ), Clinical Global Improvement Scale (CGI), General Health Questionnaire (GHQ-28), Beck Anxiety Inventory (BAI), Beck Depression Inventory-II (BDIII), and Pittsburgh Sleep Quality Index (PSQI) were among the tools used for data collection.
Analysis of study data was done using SPSS-25 and p<.05 was regarded as significant. CBGT-I was efficient in enhancing sleep quality (η2=.790), depression (η2=.616), anxiety (η2=.682), and overall psychological health (η2=.871) when compared to the control group. Subjects in CBGT-I showed significant improvement post-treatment, expressed satisfaction with the treatment they received and reported positive therapeutic relationships.
Thus, among haemodialysis patients, CBGT-I use is beneficial in lowering anxiety and depression as well as enhancing overall psychological wellness and quality of sleep. For these individuals, CBGT-I can be utilized as supplemental therapy.
Behavioural and Cognitive Psychotherapy
Cognitive behavioural group therapy for insomnia (CBGT-I) in patients undergoing haemodialysis: a randomized clinical trial
Hossein Shareh et al.
Comments (0)